| Product NDC: | 49884-404 |
| Proprietary Name: | METOPROLOL SUCCINATE |
| Non Proprietary Name: | Metoprolol succinate |
| Active Ingredient(s): | 25 mg/1 & nbsp; Metoprolol succinate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49884-404 |
| Labeler Name: | Par Pharmaceutical Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019962 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20061121 |
| Package NDC: | 49884-404-10 |
| Package Description: | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (49884-404-10) |
| NDC Code | 49884-404-10 |
| Proprietary Name | METOPROLOL SUCCINATE |
| Package Description | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (49884-404-10) |
| Product NDC | 49884-404 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Metoprolol succinate |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20061121 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Par Pharmaceutical Inc. |
| Substance Name | METOPROLOL SUCCINATE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |